Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Atrichia with papular lesions is a rare inherited form of alopecia characterized by irreversible hair loss during the neonatal period on all hear-bearing areas of the body, later associated with the development of papular lesions all over the body and preferentially on the face and extensor surfaces of the extremities.
Features include: Generalized papillary lesions and Sparse hair.
HR encodes HR lysine demethylase and nuclear receptor corepressor (1,189 aa). Histone demethylase that specifically demethylates both mono- and dimethylated 'Lys-9' of histone H3. Highest expression in Skin Not Sun Exposed Suprapubic (102.2 TPM) and Skin Sun Exposed Lower leg (94.6 TPM).
Atrichia with papular lesions is associated with mutations in the HR gene on chromosome 8.
The HR protein participates in RIC1-RGP1 exchanges GTP for GDP on RAB6, RIC1:RGP1 stimulates nucleotide RAB6 nucleotide exchange, and RIC1:RGP1 recruits RAB6:GDP to the TGN pathways.
HR is classified as a druggable target (Nuclear Hormone Receptor category) with score 17.4.
Genetic testing for HR is available. Testing is considered confirmatory for diagnosis.
Biomarker and diagnostic research for atrichia with papular lesions has been reported in the published literature.
No clinical trials have been registered for atrichia with papular lesions.
6 publications have been identified in PubMed for atrichia with papular lesions. Research spans Case Report / Case Series (50%), Diagnostic / Biomarker (17%), and Clinical Trial Publication (17%).
Burnouf T (2026). [PMID: 41482892](https://pubmed.ncbi.nlm.nih.gov/41482892/). *J Feline Med Surg*. [Clinical Trial Publication]
Alibrahim NH (2026). [PMID: 42103326](https://pubmed.ncbi.nlm.nih.gov/42103326/). *J Int Med Res*. [Case Report / Case Series]
Ullah K (2025). [PMID: 38923025](https://pubmed.ncbi.nlm.nih.gov/38923025/). *J Dermatol*. [Epidemiology / Natural History]
Yadav N (2025). [PMID: 40162362](https://pubmed.ncbi.nlm.nih.gov/40162362/). *Indian J Dermatol*. [Diagnostic / Biomarker]
Sarojadevi HS (2025). [PMID: 40654561](https://pubmed.ncbi.nlm.nih.gov/40654561/). *Int J Trichology*. [Case Report / Case Series]
Data assembled from 6 of 12 sources · Last updated Sep 19, 2026, 2:54 PM UTC
Online Mendelian Inheritance in Man
European rare disease database
Genetic and Rare Diseases Info Center